Nasdaq · CIK 0001541157
AKTX Akari Therapeutics Plc
Insider trading from SEC Form 4. Last filing 11 d ago. Close $8.77 on Oct 9, 2026, +187% from the 52-week low and -79% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
AKTXOct 9, 2026 · close 8.77
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Akari Therapeutics Plc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Abizer Gaslightwala CEO buy | $20k 21,000 shares | +8% | +6% from low-74% from high | |
| 30Weak | Abizer Gaslightwala President & CEO buy | $7,120 6,146 shares | +2% | - | |
| 30Weak | Abizer Gaslightwala President & CEO buy | $12k 10,000 shares | +4% | - | |
| 28Weak | Abizer Gaslightwala President & CEO buy | $18k 15,000 shares | +6% | - |
Transactions
The last 98 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Abizer Gaslightwala CEO | AGrant or award American Depositary Shares representing Ordinary Shares | +6,430 | $9.72 | $62k | 14,107 | 11 d ago |
| Dec 16, 2025 | Robert B Bazemore director | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +123,731 | - | - | 123,731 | Dec 18, 2025 |
| Dec 16, 2025 | Raymond Prudo-Chlebosz director | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +618,658 | - | - | 618,658 | Dec 18, 2025 |
| Dec 16, 2025 | Sandip I Patel director | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +247,462 | - | - | 247,462 | Dec 18, 2025 |
| Dec 16, 2025 | Hoyoung Huh director, owner | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +618,658 | - | - | 618,658 | Dec 18, 2025 |
| Dec 16, 2025 | Kameel D. Farag Interim CFO | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +24,745 | - | - | 24,745 | Dec 18, 2025 |
| Dec 16, 2025 | Samir Rashmikant Patel director, owner | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +618,658 | - | - | 618,658 | Dec 18, 2025 |
| Dec 16, 2025 | Abizer Gaslightwala CEO | POpen-market purchase Warrants to purchase American Depositary Shares ("ADRs")derivative | +309,328 | - | - | 309,328 | Dec 18, 2025 |
| Dec 16, 2025 | Abizer Gaslightwala CEO | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +309,328 | $0.40 | $125k | 309,328 | Dec 18, 2025 |
| Dec 16, 2025 | Samir Rashmikant Patel director, owner | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +618,658 | $0.40 | $250k | 618,658 | Dec 18, 2025 |
| Dec 16, 2025 | Kameel D. Farag Interim CFO | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +24,745 | $0.40 | $9,999 | 24,745 | Dec 18, 2025 |
| Dec 16, 2025 | Hoyoung Huh director, owner | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +618,658 | $0.40 | $250k | 618,658 | Dec 18, 2025 |
| Dec 16, 2025 | Raymond Prudo-Chlebosz director | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +618,658 | $0.40 | $250k | 618,658 | Dec 18, 2025 |
| Dec 16, 2025 | Sandip I Patel director | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +247,462 | $0.40 | $100k | 247,462 | Dec 18, 2025 |
| Dec 16, 2025 | Robert B Bazemore director | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +123,731 | $0.40 | $50k | 123,731 | Dec 18, 2025 |
| Dec 16, 2025 | Abizer Gaslightwala CEO | POpen-market purchase Warrants to purchase ADRsderivative | +773,323 | - | - | 773,323 | Dec 18, 2025 |
| Dec 16, 2025 | Samir Rashmikant Patel director, owner | POpen-market purchase Warrants to purchase ADRsderivativeindirect: PranaBio Investments LLC | +231,997 | - | - | 231,997 | Dec 18, 2025 |
| Dec 16, 2025 | Raymond Prudo-Chlebosz director | POpen-market purchase Warrants to purchase ADRsderivative | +386,661 | - | - | 386,661 | Dec 18, 2025 |
| Dec 16, 2025 | Hoyoung Huh director, owner | POpen-market purchase Warrants to purchase ADRsderivative | +3,093,293 | - | - | 3,093,293 | Dec 18, 2025 |
| Dec 16, 2025 | Robert B Bazemore director | POpen-market purchase Warrants to purchase ADRsderivative | +30,932 | - | - | 30,932 | Dec 18, 2025 |
| Dec 16, 2025 | Sandip I Patel director | POpen-market purchase Warrants to purchase ADRsderivative | +154,664 | - | - | 154,664 | Dec 18, 2025 |
| Dec 16, 2025 | Abizer Gaslightwala CEO | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +773,323 | $0.40 | $312k | 773,323 | Dec 18, 2025 |
| Dec 16, 2025 | Raymond Prudo-Chlebosz director | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +386,661 | $0.40 | $156k | 386,661 | Dec 18, 2025 |
| Dec 16, 2025 | Sandip I Patel director | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +154,664 | $0.40 | $62k | 154,664 | Dec 18, 2025 |
| Dec 16, 2025 | Hoyoung Huh director, owner | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +3,093,293 | $0.40 | $1.2M | 3,093,293 | Dec 18, 2025 |
| Dec 16, 2025 | Robert B Bazemore director | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivative | +30,932 | $0.40 | $12k | 30,932 | Dec 18, 2025 |
| Dec 16, 2025 | Samir Rashmikant Patel director, owner | POpen-market purchase Pre-Funded Warrants to purchase ADRsderivativeindirect: PranaBio Investments LLC | +231,997 | $0.40 | $94k | 231,997 | Dec 18, 2025 |
| Nov 1, 2025 | Kameel D. Farag Interim CFO | AGrant or award American Depositary Shares representing Ordinary Shares | +32,000 | $0.75 | $24k | 32,000 | Nov 4, 2025 |
| Nov 1, 2025 | Kameel D. Farag Interim CFO | AGrant or award American Depositary Shares representing Ordinary Shares | +26,619 | $0.75 | $20k | 26,619 | Nov 4, 2025 |
| Oct 22, 2025 | Kameel D. Farag Interim CFO | AGrant or award American Depositary Shares representing Ordinary Shares | +6,277 | $0.74 | $4,645 | 6,277 | Oct 24, 2025 |
| Aug 21, 2025 | Abizer Gaslightwala CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +10,000 | $0.94 | $9,400 | 287,574 | Aug 29, 2025 |
| Aug 22, 2025 | Abizer Gaslightwala CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +8,000 | $0.93 | $7,440 | 295,574 | Aug 29, 2025 |
| Aug 25, 2025 | Abizer Gaslightwala CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +3,000 | $0.90 | $2,700 | 298,574 | Aug 29, 2025 |
| Jun 23, 2025 | Abizer Gaslightwala President & CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +943 | $1.15 | $1,084 | 272,371 | Jun 25, 2025 |
| Jun 24, 2025 | Abizer Gaslightwala President & CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +5,203 | $1.16 | $6,035 | 277,574 | Jun 25, 2025 |
| Jun 20, 2025 | Abizer Gaslightwala President & CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +10,000 | $1.20 | $12k | 271,428 | Jun 24, 2025 |
| Jun 17, 2025 | Abizer Gaslightwala President & CEO | POpen-market purchase American Depositary Shares representing Ordinary Shares | +15,000 | $1.20 | $18k | 261,428 | Jun 20, 2025 |
| Jun 12, 2025 | Abizer Gaslightwala CEO | AGrant or award American Depositary Shares representing Ordinary Shares | +20,000 | $1.23 | $25k | 221,428 | Jun 16, 2025 |
| Jun 13, 2025 | Abizer Gaslightwala CEO | AGrant or award American Depositary Shares representing Ordinary Shares | +25,000 | $1.19 | $30k | 246,428 | Jun 16, 2025 |
| Jun 10, 2025 | Abizer Gaslightwala CEO | AGrant or award American Depositary Shares representing Ordinary Shares | +20,000 | $1.27 | $25k | 201,428 | Jun 12, 2025 |
| Mar 6, 2025 | Sandip I Patel director | AGrant or award American Depositary Shares representing Ordinary Shares | +44,642 | $1.12 | $50k | 496,499 | Apr 29, 2025 |
| Mar 6, 2025 | Sandip I Patel director | AGrant or award Series A Warrants (Right to Buy)derivative | +44,642 | $1.12 | $50k | 44,642 | Apr 29, 2025 |
| Mar 6, 2025 | Sandip I Patel director | AGrant or award Series B Warrants (Right to Buy)derivative | +44,642 | $1.12 | $50k | 44,642 | Apr 29, 2025 |
| Mar 20, 2025 | Torsten Hombeck CFO | AGrant or award Stock Option (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Mar 24, 2025 |
| Mar 20, 2025 | Robert B Bazemore director | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | James R Neal director | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | Abizer Gaslightwala CEO | AGrant or award Stock Option (Right to Buy)derivative | +1,100,000 | $0.00 | $0 | 1,100,000 | Mar 24, 2025 |
| Mar 20, 2025 | Abizer Gaslightwala CEO | AGrant or award Stock Option (Right to Buy)derivative | +600,000 | $0.00 | $0 | 600,000 | Mar 24, 2025 |
| Mar 20, 2025 | Torsten Hombeck CFO | AGrant or award Stock Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Mar 24, 2025 |
| Mar 20, 2025 | Hoyoung Huh director, owner | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | Samir Rashmikant Patel director | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | Robert B Bazemore director | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 20, 2025 | James R Neal director | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 20, 2025 | Hoyoung Huh director, owner | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 20, 2025 | Raymond Prudo-Chlebosz director | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | Samir Rashmikant Patel director | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 20, 2025 | Raymond Prudo-Chlebosz director | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 20, 2025 | Sandip I Patel director | AGrant or award Stock Option (Right to Buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Mar 24, 2025 |
| Mar 20, 2025 | Sandip I Patel director | AGrant or award Stock Option (Right to Buy)derivative | +225,000 | $0.00 | $0 | 225,000 | Mar 24, 2025 |
| Mar 6, 2025 | Abizer Gaslightwala CEO | AGrant or award American Depositary Shares representing Ordinary Shares | +133,928 | $1.12 | $150k | 181,428 | Mar 10, 2025 |
| Mar 6, 2025 | James R Neal director | AGrant or award American Depositary Shares representing Ordinary Shares | +4,464 | $1.12 | $5,000 | 36,271 | Mar 10, 2025 |
| Mar 6, 2025 | Samir Rashmikant Patel director | AGrant or award American Depositary Shares representing Ordinary Sharesindirect: PranaBio Investments LLC | +406,250 | $1.12 | $455k | 3,031,005 | Mar 10, 2025 |
| Mar 6, 2025 | Robert B Bazemore director | AGrant or award American Depositary Shares representing Ordinary Shares | +44,642 | $1.12 | $50k | 44,642 | Mar 10, 2025 |
| Mar 6, 2025 | Raymond Prudo-Chlebosz director | AGrant or award American Depositary Shares representing Ordinary Shares | +446,428 | $1.12 | $500k | 2,484,990 | Mar 10, 2025 |
| Mar 6, 2025 | Hoyoung Huh director, owner | AGrant or award American Depositary Shares representing Ordinary Shares | +892,857 | $1.12 | $1000k | 4,695,854 | Mar 10, 2025 |
| Mar 6, 2025 | Robert B Bazemore director | AGrant or award Series A Warrants (Right to Buy)derivative | +44,642 | $1.12 | $50k | 44,642 | Mar 10, 2025 |
| Mar 6, 2025 | Abizer Gaslightwala CEO | AGrant or award Series A Warrants (Right to Buy)derivative | +133,928 | $1.12 | $150k | 133,928 | Mar 10, 2025 |
| Mar 6, 2025 | James R Neal director | AGrant or award Series A Warrants (Right to Buy)derivative | +4,464 | $1.12 | $5,000 | 4,464 | Mar 10, 2025 |
| Mar 6, 2025 | Robert B Bazemore director | AGrant or award Series B Warrants (Right to Buy)derivative | +44,642 | $1.12 | $50k | 44,642 | Mar 10, 2025 |
| Mar 6, 2025 | Hoyoung Huh director, owner | AGrant or award Series A Warrants (Right to Buy)derivative | +892,857 | $1.12 | $1000k | 892,857 | Mar 10, 2025 |
| Mar 6, 2025 | Samir Rashmikant Patel director | AGrant or award Series A Warrants (Right to Buy)derivativeindirect: PranaBio Investments LLC | +406,250 | $1.12 | $455k | 406,250 | Mar 10, 2025 |
| Mar 6, 2025 | James R Neal director | AGrant or award Series B Warrants (Right to Buy)derivative | +4,464 | $1.12 | $5,000 | 4,464 | Mar 10, 2025 |
| Mar 6, 2025 | Abizer Gaslightwala CEO | AGrant or award Series B Warrants (Right to Buy)derivative | +133,928 | $1.12 | $150k | 133,928 | Mar 10, 2025 |
| Mar 6, 2025 | Raymond Prudo-Chlebosz director | AGrant or award Series A Warrants (Right to Buy)derivative | +446,428 | $1.12 | $500k | 446,428 | Mar 10, 2025 |
| Mar 6, 2025 | Samir Rashmikant Patel director | AGrant or award Series B Warrants (Right to Buy)derivativeindirect: PranaBio Investments LLC | +406,250 | $1.12 | $455k | 406,250 | Mar 10, 2025 |
| Mar 6, 2025 | Hoyoung Huh director, owner | AGrant or award Series B Warrants (Right to Buy)derivative | +892,857 | $1.12 | $1000k | 892,857 | Mar 10, 2025 |
| Mar 6, 2025 | Raymond Prudo-Chlebosz director | AGrant or award Series B Warrants (Right to Buy)derivative | +446,428 | $1.12 | $500k | 446,428 | Mar 10, 2025 |
| Jan 10, 2025 | Torsten Hombeck CFO | AGrant or award American Depository Shares representing Ordinary Shares | +200 | $1.22 | $244 | 200 | Jan 13, 2025 |
| Jan 10, 2025 | Abizer Gaslightwala CEO | AGrant or award American Depository Shares representing Ordinary Shares | +11,439 | $1.22 | $14k | 35,860 | Jan 13, 2025 |
| Jan 9, 2025 | James R Neal director | AGrant or award Ordinary Shares, par value $0.0001 per share | +8,000,000 | $0.00 | $4,800 | 32,216,000 | Jan 10, 2025 |
| Jan 3, 2025 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +208,000 | $0.00 | $125 | 5,249,511,500 | Jan 7, 2025 |
| Jan 3, 2025 | Abizer Gaslightwala CEO | AGrant or award Ordinary Shares, par value $0.0001 per share | +1,720,000 | $0.00 | $1,032 | 71,720,000 | Jan 7, 2025 |
| Jan 3, 2025 | Samir Rashmikant Patel director | AGrant or award Stock Option (Right to Buy)derivative | +152,672,000 | $0.00 | $0 | 152,672,000 | Jan 7, 2025 |
| Dec 27, 2024 | Abizer Gaslightwala CEO | AGrant or award Ordinary Shares, par value $0.0001 per share | +40,000,000 | $0.00 | $20k | 70,000,000 | Dec 30, 2024 |
| Dec 26, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +3,200,000 | $0.00 | $1,600 | 5,248,903,500 | Dec 30, 2024 |
| Dec 27, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +400,000 | $0.00 | $200 | 5,249,303,500 | Dec 30, 2024 |
| Dec 26, 2024 | Abizer Gaslightwala CEO | AGrant or award Ordinary Shares, par value $0.0001 per share | +30,000,000 | $0.00 | $15k | 30,000,000 | Dec 27, 2024 |
| Dec 24, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +7,500,000 | $0.00 | $3,750 | 5,245,703,500 | Dec 27, 2024 |
| Dec 23, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +1,400,000 | $0.00 | $700 | 5,238,203,500 | Dec 26, 2024 |
| Dec 20, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +1,400,000 | $0.00 | $700 | 5,236,803,500 | Dec 26, 2024 |
| Dec 23, 2024 | James R Neal director | AGrant or award Ordinary Shares, par value $0.0001 per share | +2,000,000 | $0.00 | $1,000 | 24,216,000 | Dec 26, 2024 |
| Dec 2, 2024 | Raymond Prudo-Chlebosz director | AGrant or award Ordinary Shares, par value $0.0001 per share | +419,286,000 | $0.00 | $503k | 4,077,124,600 | Dec 3, 2024 |
| Dec 2, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +419,286,000 | $0.00 | $503k | 5,235,403,500 | Dec 3, 2024 |
| Nov 30, 2024 | Samir Rashmikant Patel director | AGrant or award Stock Option (Right to Buy)derivative | +162,604,000 | $0.00 | $0 | 162,604,000 | Dec 3, 2024 |
| Dec 2, 2024 | Raymond Prudo-Chlebosz director | AGrant or award Warrants (Right to Buy)derivative | +419,286,000 | $0.00 | $503k | 419,286,000 | Dec 3, 2024 |
| Dec 2, 2024 | Samir Rashmikant Patel director | AGrant or award Warrants (Right to Buy)derivativeindirect: PranaBio Investments LLC | +419,286,000 | $0.00 | $503k | 419,286,000 | Dec 3, 2024 |
| Nov 14, 2024 | Samir Rashmikant Patel director | AGrant or award Ordinary Shares, par value $0.0001 per shareindirect: PranaBio Investments LLC | +1,404,622,000 | - | - | 4,816,117,500 | Nov 18, 2024 |
| Oct 31, 2024 | Samir Rashmikant Patel director | AGrant or award Stock Option (Right to Buy)derivative | +79,684,000 | $0.00 | $0 | 79,684,000 | Nov 1, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Robert B Bazemoredirector
- Kameel D. FaragInterim CFO
- Abizer GaslightwalaCEO
- Torsten HombeckCFO
- Hoyoung Huhdirector, owner
- James R Nealdirector
- Samir Rashmikant Pateldirector, owner
- Sandip I Pateldirector, cfo, officer
- Raymond Prudo-Chleboszdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.